Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This term refers to a collective group of structural and functional proteins that maintain the integrity and flow properties of red blood cells (RBCs). The erythrocyte membrane is composed of a lipid bilayer anchored to a complex protein cytoskeleton, including spectrin, ankyrin, and actin, which allows the cell to undergo extreme deformation while passing through narrow capillaries (Mohandas & Gallagher, 2008). Blood rheology is the study of blood flow and is influenced by these membrane components, as well as plasma factors like fibrinogen and the internal viscosity of the RBC, primarily determined by hemoglobin (Baskurt & Meiselman, 2003). Integral membrane proteins like Band 3 and glycophorins also play critical roles in ion transport and preventing cell aggregation. Pathological changes in these proteins can lead to hemolytic anemias, such as hereditary spherocytosis, or contribute to the microvascular complications of diabetes and sickle cell disease (Da Costa et al., 2013). Therapeutic agents like pentoxifylline target these components to enhance RBC flexibility and reduce blood viscosity, thereby improving tissue perfusion in ischemic conditions (Ward & Clissold, 1987). Other drugs, such as voxelotor, specifically target hemoglobin to prevent the polymerization that stiffens the membrane in sickle cell disease (Vichinsky et al., 2019). Monitoring rheological parameters is essential for assessing the efficacy of treatments for peripheral vascular disorders and microcirculatory failure.
Improvement of erythrocyte deformability, reduction of blood viscosity, and stabilization of the membrane-cytoskeleton interaction to enhance microcirculatory flow.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Erythrocyte membrane components and blood rheology-related proteins.